CLINICAL_TRIALS
trial_result
· 2022-06-21
Clinical Trial Update: BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC [Phase 1, Phase 2]
Summary
Phase Ib/II trial evaluating ONC201 plus nivolumab in metastatic colorectal cancer has been terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brown University | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-06-21